Internal Server Error

About Samarsh Capital

Samarsh Capital is a venture capital firm founded in 2024. It is primarily based out of Bengaluru, India. As of Jul 2025, Samarsh Capital has invested in 3 companies. It primarily invests in Seed round in India based startups. Its investments are spread across a wide range of sectors from Environment Tech to Life Sciences and Semiconductors. Most recently it participated in the $***** Series A round of SAI Parenterals Overall, Samarsh Capital portfolio has seen 1 IPO, namely SAI Parenterals. A lot of funds co-invest with Samarsh Capital, with names like Blue Lotus Capital sharing a substantial percentage of its portfolio. Samarsh Capital has team of 6 people including 1 partners.
Key Metrics
Team Members
Portfolio Count
Portfolio Locations
Rounds of Entry
Seed & Series A
Portfolio IPOs

Samarsh Capital's List of All Investments

Samarsh Capital has a portfolio of 3 companies. Their most notable investments are in Agrileaf and SAI Parenterals.Their portfolio spans across and India. They have invested in Environment Tech, Life Sciences, Semiconductors and 2 other sectors, across stages such as Seed, Series A stages. Here is the list of all investments by Samarsh Capital:
Provider of parenteral products and pharmaceutical services. It offers sterile dry powder injections and sterile liquid injections, including prefilled syringes, ampoules, and vials. Its facilities includes a range of products, including oral tablets, capsules, liquids, ointments, gels, and exclusive cephalosporin formulations.

Key facts about SAI Parenterals

  • Founded Year: 2001
  • Location: Hyderabad (India)
  • Annual Revenue: ₹100 - ₹500 Cr as on Mar 31, 2025
  • Stage: Public
  • Total Funding till date: $5.83M
  • Employee Count: 257 as on Dec 31, 2024
  • Investors: MYCap Investments, Samarsh Capital and 3 Others
  • Latest Funding Round: Series A, Jul 08, 2025, $*****
  • Highlight: Public
Manufacturer of metal, plastic, and electronic precision parts. It provides handling design, stamping, injection molding, manufacturing, and order fulfillment services. The company offers end-to-end solutions from design to production, focusing on innovation and industry leading technologies.

Key facts about Rikun

Manufacturer of eco-friendly disposable areca palm leaf plates. It produces agricultural bio-products, such as disposable plates made from Areca palm leaves. It focuses on creating sustainable dinnerware and food platters using readily available fallen areca leaves. It offers a range of use-and-throw food plates that provide a green alternative to plastic, bamboo and paper plates.

Key facts about Agrileaf

  • Founded Year: 2019
  • Location: Mangaluru (India)
  • Annual Revenue: ₹10 - ₹50 Cr as on Mar 31, 2025
  • Valuation: $*****
  • Stage: Seed
  • Total Funding till date: $2M
  • Employee Count: 86 as on May 31, 2025
  • Investors: Capital-A, Samarsh Capital and 10 Others
  • Latest Funding Round: Seed, Sep 18, 2024, $*****
  • Highlight: Editors' Pick

Samarsh Capital's Investments by Stage

Samarsh Capital has made 1 investment in Seed stage with an average round size of $2M and 1 investment in Series A stage with an average round size of $5.83M.

Samarsh Capital's Investments by Sector

Samarsh Capital has a diverse portfolio, with companies operating in the Environment Tech, Healthcare, Industrial Goods and Manufacturing, Life Sciences and Sustainability Tech. Notably, it has invested in 2 Enterprise (B2B) companies, 1 Consumer (B2C) company, 1 Social impact company and 1 company focusing on Tech.
Here are Samarsh Capital's investments by sector:
Sector
No. of Investments
Environment Tech
1
Healthcare
1
Industrial Goods and Manufacturing
1
Life Sciences
1
Sustainability Tech
1
Breakdown of Samarsh Capital's investments by sectorsEnvironment Tech (1)Healthcare (1)
Note: We have considered here, only first round of investments

Samarsh Capital's Investments by Geography

Samarsh Capital has made most investments in India (2).

Samarsh Capital's recent investments

Samarsh Capital has not made any investment in 2026 so far.
Here are the most recent investments by Samarsh Capital:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Jul 08, 2025
India
Series A
1158
Sep 18, 2024
India
Seed
2487

IPOs and Publicly Listed companies in Samarsh Capital's Portfolio

1 of Samarsh Capital's portfolio company became public -  SAI Parenterals. It got listed on the Bombay Stock Exchange (BSE), National Stock Exchange (NSE), in Apr 2026 at marketcap of $185M
Here are Samarsh Capital's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Apr 02, 2026
Jul 08, 2025
Series A
3742

Team profile of Samarsh Capital

Samarsh Capital has a team of 6 members located in India. Samarsh Capital's team does not sit on the board of any company as of now.

Co-investors of Samarsh Capital

Over the past 2 years, 13 investors have co-invested in Samarsh Capital's portfolio companies. This includes funds and angels.

  • Top Co-investors of Samarsh Capital: 13 investors entered a company along with Samarsh Capital. These include investors like Blue Lotus Capital (1 company).

Recent News related to Samarsh Capital

View all news related to Samarsh Capital

FAQs about Samarsh Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford